Skou AS, Juul-Dam KL, Ommen HB, Hasle H, et al. Peripheral blood molecular measurable residual disease is sufficient to identify patients with acute myeloid leukaemia with imminent clinical relapse. Br J Haematol 2021;195:310-327.
PMID: 33851435